Clear Trial Podcast: Episode 3- Examines pros and cons of clinical trial forecasting & budgeting methods in use today - Pharmaceutical Executive

ADVERTISEMENT

Trends in Assessing Internal and Outsourced Clinical Trial Costs and Resource Demand
Join Reid Paul, Editor in Chief of Pharmaceutical Representative, Ken Getz, Senior Research Fellow at the Tufts Center for the Study of Drug Development, and Andy Grygiel, Vice President of Marketing and Product Management at ClearTrial, for Parts 1 and 2 of this podcast series as we discuss recent Tufts research on assessing clinical trial costs and resource demand. In Part 3 of the series, Molly Blake-Michaels, Director, Clinical Services at ClearTrial, to examines the pros and cons of the most widely used clinical trial forecasting and budgeting methods in use today by biopharmaceutical and medical device companies.

Episode 3: Molly Blake-Michaels, Director, Clinical Services at ClearTrial, examines the pros and cons of the most widely used clinical trial forecasting and budgeting methods in use today by biopharmaceutical and medical device companies.

Speaker:
Molly Blake-Michaels
Director,
Clinical Services
Clear Trial




Add this Podcast feed to your media player

Click Here To Listen to More of the Clear Trial Podcast Series

 


Sponsored By
ClearTrial provides Clinical Trial Operations software that makes the planning, forecasting, and tracking of clinical project and financial performance faster and more accurate.


Click here